glp-1 and cholesterol Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, Emerging Therapies Research Progress on the Association

Practical Considerations in Diabetes Care When considering GLP1 therapy in patients with diabetes who also consume alcohol, clinicians should balance potential metabolic and weight benefits with individual patient goals and risks

Patient Factors That Amplify the Risk Diabetic gastroparesis, opioid co-administration, and anticholinergic burden each slow gastric motility independently

Direct receptor-mediated effects This is where things get scientifically fascinating

in diabetic rodents, Fan and colleagues [77] demonstrated that intravitreal exedin-4 injection reduced retinal cell loss, maintained Bcl-2/Bax ratios, whose imbalance is associated with retinal cell apoptosis, prevented activation of pro-apoptotic AKT, and prevented excess reactive gliosis

However, this is harder to self-administer correctly, so we usually recommend sticking with the thigh or stomach